Drug Approval | October 04, 2024
Shilpa Pharma Lifesciences receives CEP from EDQM for API, Desmopressin
This is used to treat central diabetes insipidus and bedwetting
This is used to treat central diabetes insipidus and bedwetting
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
The inspection conducted by EDQM at its Visakhapatnam facility
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Potential of Ayurveda’s contribution in global health system through various innovative practices
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
Subscribe To Our Newsletter & Stay Updated
